InvestorsHub Logo
icon url

The Other Guy

04/12/18 10:04 PM

#326122 RE: jakedogman1 #326121

Oncologie is but a few months old. How can you say the ip is in good hands?

I still think it’s a very suspicious situation. Finding the $8 Million trail will be more difficult than tracing $130k paid to some porn star to keep quiet.
icon url

geocappy1

04/12/18 10:38 PM

#326124 RE: jakedogman1 #326121

Well, since we did a deal that involves potential future payments I think we as SHs have a right to know more about Oncologie and their capabilities. You are right in that Oncologie owes us nothing. However, our own BOD does owes us this information and they should have it if they were ok with a futuristic type deal.

We shouldn't have to depend on one of our posters to tell us the IP is on good hands. We are the SHs of a company who did a "on the come" deal and our BOD should know and tell us more about who Oncologie is and their likelihood of developing the IP

Their secrecy is very telling
icon url

Wernaaa

04/13/18 12:06 PM

#326136 RE: jakedogman1 #326121

My source says, it’s in bad hands, in the hands of the old crew! Let’s see who has the better „source“

AIMO!!!!
icon url

vinmantoo

04/13/18 12:50 PM

#326138 RE: jakedogman1 #326121

My source says the tech is in good hands. Oncologie is a private firm and my guess is that they could care less about a website and telegraphing to the world what they plan on doing. Do you think they give a rat's arse about cdmo retail shareholders? We're not on their make happy list. Would I have preferred BP paid a bunch more on the front end? Yes. But a small firm focused on a few shots on goal versus a BP with hundreds of shots on goal?



The exact opposite is true. I can't believe I have to say this. You want a big company with a lot of financial resources, long expertise on developing oncology drugs and determining the best and most rapid pathway through clinical trials and who also through experience, knows the FDA submission/approval process like the back of their hand. Bavi has a poor MOA and was a prayer but for years and years was being touted by unscrupulous management as the Holy Grail. The price PPHM/CDMO got for their IP and who they sold it to should make that crystal clear.

Building CDMO is a far better way for old PPHM investors to get at least some of their money back. If the new management doesn't have several new clients which significantly increase revenues, say in about a year, then you should start worrying.